{{Rsnum
|rsid=11617740
|Gene=FGF14
|Chromosome=13
|position=102027776
|Orientation=plus
|GMAF=0.03673
|Gene_s=FGF14
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 12.4 | 86.7
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 5.3 | 94.7
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 10.9 | 89.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.0 | 2.6 | 97.4
| TSI | 1.0 | 19.6 | 79.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23551011
  |Trait=Preeclampsia
  |Title=Genome-Wide Association Study of Pre-Eclampsia Detects Novel Maternal Single Nucleotide Polymorphisms and Copy-Number Variants in Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cohort.
  |RiskAllele=
  |Pval=7E-7
  |OR=16.69
  |ORtxt=[5.53-51.97]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}